Fungal cell-wall antigens for the diagnosis of invasive fungal infections

The Fungal Cell Wall

Volumn , Issue , 2013, Pages 199-231

  Ruiz Baca, Estela ^a   Cuéllar Cruz, Mayra ^b   López Romero, Everardo ^c   Reyes Montes, María del Rocío ^d   Toriello, Conchita ^d  

^a UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

^b CENTRO DE INVESTIGACIÓN Y ASISTENCIA EN TECNOLOGÍA Y DISEÑO DEL ESTADO DE JALISCO   (Mexico)

^c UNIVERSITY OF GUANAJUATO   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84895384798     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (261)

1. Gullo A. Invasive fungal infections: the challenge continues. Drugs. 2009; 69:65-73.
2. Jain A, Jain S, Rawat S. Emerging fungal infections among children: A review on its clinical manifestations, diagnosis, and prevention. J. Pharm. Bioallied Sci. 2010. 2:314-320.
3. Chian-Yong L and Coleman R. Emerging fungal infections in immunocompromised patients. F1000 Med. Resp. 2011; 3:14.
4. Wisplinghoff HT, Bischoff S, Tallent M, Seifert H, Wenzel RP and Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 2004; 39:309-317.
5. Singh N and Paterson DL. Aspergillus infections in transplant recipients. Clin. Microbiol. Rev. 2005; 18:44-69.
6. Ampel NM. Emerging disease issues and fungal pathogens associated with HIV infection. Emerg. Infect. Dis. 1996; 2:109-116.
7. Ellepola, AN and Morrison CJ. Laboratory diagnosis of invasive candidiasis. J. Microbiol. 2005; 43:65-84.
8. Kojic EM and Darouiche RO. Candida infections of medical devices. Clin. Microbiol. Rev. 2004; 17:255-267.
9. Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS and Bearden DT. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin. Infect. Dis. 2006; 43:25-31.
10. Senn L, James Owen JR,1 Schmidt S, Knaup M, Asahi N, Satomura S, Matsuura S, Duvoisin B, Bille J, Calandra T and Marchetti O. 1,3-β-D-Glucan Antigenemia forearly diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin. Infec. Dis. 2008; 46:878-85.
11. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, and Walsh TJ. Defining opportunistic IFI in immunocompromised patients with cancer and hematopoietic stem cell transplants; an international consensus. Clin. Infect. Dis. 2002; 34:7-14.
12. Pickering JW, Sant HW, Bowles CA, Roberts WL and Woods GL. Evaluation of a (1r3)-β-D-glucan assay for diagnosis of invasive fungal infections. J. Clin. Microbiol. 2005; 43:5957-62.
13. Stevens DA. Diagnosis of fungal infections: current status. J. Antimicrob. Chemother. 2002; 49:11-19.
14. Klastersky J. Empirical antifungal therapy. Int. J. Antimicrob. Agents; 2004; 23:105- 112.
15. Mennink-Kersten MA, Donnelly JP and Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect. Dis. 2004; 4:349-357.
16. De Pauw BE. Between over- and undertreatment of invasive fungal disease. Clin. Infect. Dis. 2005; 41:1251-1253.
17. Segal BH, Almyroudis NG, Battiwalla M, Herbrecht R, Perfect JR, Walsh TJ and Wingard JR. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broadspectrum antifungal agents and diagnostic adjuncts. Clin. Infect. Dis. 2007; 44:402- 409.
18. Repentigny de L, Kaufman L, Cole GT, Kruse D, Latgé JP and Matthews RC. Immunodiagnosis of invasive fungal infections. J. Med. Vet. Mycol. 1994; 32:239-252.
19. Elias-Costa MR, Da Silva-Lacaz C, Kawasaki M and De Camargo ZP. Conventional versus molecular diagnostic test. Med. Mycol. 2000; 38:139-145.
20. Jones BL and McLintock LA. Impact of Diagnostic markers on early antifungal therapy. Curr. Opin. Infect. Dis. 2003; 16:521-526.
21. Pitarch A, Gil C and Nombela-Cano C. La inmunoproteómica en el descubrimiento de biomarcadores de tercera generación. El ejemplo de las candidiasis invasivas. Biomarcadores: Analítica, Diagnóstico y Terapéutica. Cap. 2. 2010.
22. Masuoka J. Surface glycans of Candida albicans and othter pathogenic fungi: physiological roles, clinical uses, and experimental challenges. Clin. Microb. Rev. 2004; 17:281-310
23. Xianfa X and Peter NL. On the evolution of fungal and yeast cell walls. Yeast. 2010; 27:479-488.
24. Pontón J. Omaetxebarría MJ, Elguezabal N, Alvarez M and Morangues MD. Immunoreactivity of the fungal cell wall. Med. Mycol. 2001; 39:101-110.
25. Pitarch A, Pardo M, Jiménez A, Pla J, Gil C, Sánchez M and Nombela C. Twodimensional gel electrophoresis as analytical tool for identifyin Candida albicans immunogenic proteins. Electrophoresis. 1999; 20:1001-1010.
26. Pitarch A, Jiménez A, Nombela C and Gil C. Decoding serological response to Candida cell wall immunome into novel diagnostic, prognostic, and therapeutic candidates forsystemic candidiasis by proteomic and bioinformatic analyses. Mol. Cell Proteomics. 2006; 5:79-96.
27. Pitarch A, Nombela C and Gil C. Candida albicans biology and pathogenicity. Insights from proteomics. En: Microbial proteomics: Functional biology of whole organisms (Humphery-Smith, I. & Hecker, M., Eds), 2006; p. 285-330. Wiley-Vch, New Jersey.
28. Chaffin WL. Candida albicans cell wall proteins. Microbiol. Mol. Biol. Rev. 2008; 72: 495-544.
29. Cruz Ch R and Piontelli LE. Invasive fungal disease in patients from five hospitals in the Valparaiso region, Chile: 2004 to 2009. Rev. Chilena Infectol. 2011; 28:123-129.
30. Silva S, Negri M, Henriques M, Oliveira R, Williams DW and Azeredo J. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol. Rev. 2011. doi: 10.1111/j. 1574-6976.2011.00278.x.
31. Samaranayake LP, Fidel PL, Naglik JR, Sweet SP, Teanpaisan R, Coogan MM, Blignaut E and Wanzala P. Fungal infections associated with HIV infection. Oral Dis. 2002; 8:151-160.
32. Trick WE, Fridkin SK, Edwards JR, Hajjeh RA and Gaynes RP. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin. Infect. Dis. 2002; 35:627-630.
33. Hagerty JA, Ortiz J, Reich D and Manzarbeitia C Fungal infections in solid organ transplant patients. Surg. Infect. (Larchmt) 2003; 4:263-271.
34. Bassetti M, Righi E, Costa A, Fasce R, Molinari MP, Rosso R, Pallavicini FB and Viscoli C. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect. Dis. 2006; 6:21.
35. Colombo AL, Guimaraes T, Silva LR, de Almeida Monfardini LP, Cunha AK, Rady P and Alves T, Rosas RC. Prospective observational study of candidemia in Sao Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality. Infect Control Hosp. Epidemiol. 2007; 28:570-576.
36. Pfaller MA and Diekema DJ Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 2007; 20:133-163.
37. Chakrabarti A, Chatterjee SS, Rao KL, Zameer MM, Shivaprakash MR, Singhi S, Singh R and Varma SC. Recent experience with fungaemia: change in species distribution and azole resistance. Scand J. Infect. Dis. 2009; 41:275-284.
38. Kothavade RJ, Kura MM, Valand AG and Panthaki MH. Candida tropicalis: its prevalence, pathogenicity and increasing resistance to fluconazole. J. Med. Microbiol. 2010; 59:873-880.
39. Trofa D, Gacser A and Nosanchuk JD Candida parapsilosis, an emerging fungal pathogen. Clin. Microbiol. Rev. 2008; 21:606-625.
40. Alam FF, Mustafa AS and Khan ZU. Comparative evaluation of (1,3)-β-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia. BMC Infect. Dis. 2007; 4:103.
41. Gácser A, Schäfer W, Nosanchuck JS, Salomon S and Nosanchuk JD. Virulence of Candida parapsilosis, Candida orthopilosis, and Candida metapsilosis in reconstituted human tissue models. Fungal Genet. Biol. 2007; 44:1336-1341.
42. Larone DH. Medically important fungi; a guide to identification; 4th ed. Washington: ASM Press, 409. 2002.
43. Calderone RA. Introduction and historical perspectives. In: Calderone R.A. (Eds.) Candida and candidiasis, ASM Press, Washington D.C., 2002; p. 15-25.
44. Yoshio O and Kouji G. Antigenicity of Candida tropicalis strain cells cultured at 27 and 37deg. FEMS Immunol. Med. Microbiol. 2006; 46:438-443.
45. Martin MV. Germ-tube formation by oral strains of Candida tropicalis. J. Med. Microbiol. 1979; 12:187-194.
46. Fidel PL, Vazquez JA and Sobel JD. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin. Microbiol. Rev. 1999; 12:80-96.
47. Butler G, Rasmussen MD, Lin MF, Santos MA, Sakthikumar S, Munro CA, Rheinbay E, Grabherr M, Forche A, Reedy JL, Agrafioti I, Arnaud MB, Bates S, Brown AJ, Brunke S, Costanzo MC, Fitzpatrick DA, de Groot PW, Harris D, Hoyer LL, Hube B, Klis FM, Kodira C, Lennard N, Logue ME, Martin R, Neiman AM, Nikolaou E, Quail MA, Quinn J, Santos MC, Schmitzberger FF, Sherlock G, Shah P, Silverstein KA, Skrzypek MS, Soll D, Staggs R, Stansfield I, Stumpf MP, Sudbery PE, Srikantha T, Zeng Q, Berman J, Berriman M, Heitman J, Gow NA, Lorenz MC, Birren BW, Kellis M and Cuomo CA. Evolution of pathogenicity and sexual reproduction in eight Candida genomes. Nature. 2009; 459:657-662.
48. Pontón J. El diagnóstico microbiológico independiente del cultivo en la candidiasis invasora. Importancia de los marcadores fúngicos. Rev. Iberoam. Micol. 2006; 23:20- 25.
49. Matthews RC and Burnie JP. Diagnosis of systemic candidiasis by an enzyme-linked dot immunobinding assay for a circulating immunodominant 47-kDa antigen. J. Clin. Microbiol. 1988; 26: 459-463.
50. Strockbine NA, Largen MT and Buckley HR. Production and characterization of three monoclonal antibodies to Candida albicans proteins. Infect. Immun. 1984; 43:1012- 1018.
51. Elsayed S, Fitzgerald V, Massey V, Hussain Z. Evaluation of the Candigen enzymelinked immunosorbent assay for quantitative detection of Candida species antigen. Arch. Pathol. Lab. Med. 2001; 125:344-346.
52. Philip A, Odabasi Z, Matiuzzi G, Paetznick Victor L, Tan SW, Warmington, Rex JH, Ostrosky-Zeichner L. Syscan3, a kit for detection of anti-Candida antibodies for diagnosis of invasive candidiasis. J. Clin. Microbiol. 2005; 43:4834-4835.
53. Figueras C, Diaz de Heredia C, Navarro ML, Rosello E and Alvez F. Infección fúngica invasiva (IFI): actualización. Protocolos Diagnósticos Terapéuticos de la AEP: Infectología Pediátrica. Cap. 15. 2008.
54. Hernando FL, Calvo E, Abad A, Ramírez A, Rementeria A, Sevilla MJ and Ponton J. Identification of protein and mannoprotein antigens of Candida albicans of relevance for the serodiagnosis of invasive candidiasis. Intern. Microbiol. 2007; 10:103-108.
55. Pontón J and del Palacio A. Avances y limitaciones del diagnóstico precoz de las infecciones invasoras causadas por levaduras. Rev. Iberoam. Micol. 2007; 24:181-186.
56. Oliveri S, Trovato L, Betta P, Romeo MG and Nicoletti G. Experience with the Platelia Candida ELISA for the diagnosis of invasive candidosis in neonatal patients. Clin. Microbiol. Infect. 2008; 14:391-393.
57. Odabasi Z, Mattiuzzi G, Estey E, Kantarjian H, Saeki F, Ridge RJ, Ketchum PA, Finkelman MA, Rex JH and Ostrosky-Zeichner L. β-D-glucan assay as a diagnosticadjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin. Infect. Dis. 2004; 39:199-205.
58. Ostrosky-Zeichner L, Alexander BD, Kett DH, Vazquez J, Pappas PG, Saeki F, Ketchum PA, Wingard J, Schiff R, Tamura H, Finkelman MA and Rex JH. Multicenter clinical evaluation of the (1®3)-β-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin. Infect. Dis. 2005; 41:654-659.
59. Kohno S, Mitsutake K, Maesaki S, Yasuoka A, Miyazaki T, Kaku M, Koga H and Hara K. An evaluation of serodiagnostic tests in patients with candidemia: beta-glucan, mannan, Candida antigen by Cand-Tec and D-arabinitol. Microbiol. Immunol. 1993; 37:207-212.
60. Nett JD. β-1-3 glucan as a test for central venous catheter biofilm infections. J. Infect. Dis. 2007; 195:1705-1712.
61. Montagna MT, Coretti C, Lovero G, De Giglio O, Montagna O, Laforgia N, Santoro N, and Caggiano G. Diagnostic Performance of 1→3-β-D-Glucan in Neonatal and Pediatric Patients with Candidemia. Int. J. Mol. Sci. 2011; 12:5871-5877.
62. Alexander BD, Smith PB, Davis RD, Perfect JR and Reller LB. The (1,3)β-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation. J. Clin. Microbiol. 2010; 48:4083-4088.
63. Rácil Z, Kocmanová I, Weinbergerová B, Winterová J, Lengerová M, Hrncírová K and Mayer J. Detection of 1,3-β-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results. Klin. Mikrobiol. Infekc. Lek. 2009; 15:48-57.
64. Kohno S. Serological diagnosis of deepseated mycoses. Asian Med. J. 1991; 34:460- 466.
65. Moragues MD, Ortíz N, Iruretagoyena JR, García Ruíz JC, Amutio E, Rojas A, Mendoza J, Quindós G and Pontón J. Evaluación de una nueva técnica comercializada (Candida albicans IFA IgG) para el diagnóstico de la candidiasis invasiva. Enferm. Infecc. Microbiol. Clin. 2004; 22:83-88.
66. Lain A. Diagnosis of invasive candidiasis by enzyme-linked inmunosorbent assay using the N-terminal fragment of Candida albicans Hwp1. BMC Microbiol. 2007; 7:35.
67. Coleman DA, Oh SH, Zhao X, Zhao H, Hutchins JT, Vernachio JH, Patti JM and Hoyer LL. J Microbiol. Methods. Monoclonal antibodies specific for Candida albicans Als3 that immunolabel fungal cells in vitro and in vivo and block adhesion to host surfaces. 2009; 78:71-78.
68. Laín A, Elguezabal N, Amutio E, Fernández de Larrinoa I, Moragues MD and Pontón J. Use of recombinant antigens for the diagnosis of invasive candidiasis. Clin. Dev. Immunol. 2008; 2008:721950.
69. Poulain D, Robert R, Mesnard F, Sendid B, Lepage G and Camus D. Clearances of Candida albicans derived alpha and beta linked mannose residues in sera from patients with candidosis. Eur. J. Clin. Microbiol. Infect. Dis. 1997; 16:16-20.
70. Pontón J, Moragues MD and Quindós G. Non-culture based diagnostics. In: Calderone R (Ed.). Candida and Candidiasis. Washington, American Society for Microbiology, 2002; 395-425.
71. Morace G, Sanguinetti M, Posteraro B, Lo Cascio G and Fadda G. Identification of various medically important Candida Species in clinical specimens by PCR-restriction enzyme analysis. J. Clin. Microbiol. 1997; 35:667-672.
72. Ferrer C, Colom F, Frasés S, Mulet E, Abad JL and Alio JL. Detection and identification of fungal pathogens by PCR and by ITS2 and 5.8S ribosomal DNA typing in ocular infections J. Clin. Microbiol. 2001; 39:2873-2879.
73. Mirhendi SH, Kordbacheh P, Pezeshki M and Khorramizadeh MR. Simple and rapid identification of most medically important Candida species by a PCR restriction enzyme method. Acta Med. Iran. 2003; 41:79-83.
74. Goldenberg O, Herrmann S, Adam T, Marjoram G, Hong G, Gobel UB and Graf B. Use of denaturing high-performance liquid chromatography for rapid detection and identification of seven Candida species. J. Clin. Microbiol. 2005; 43: 5912-5915.
75. Moreira-Oliveira MS. Diagnosis of candidemia by polymerase chain reaction and blood culture: prospective study in a high-risk population and identification of variables associated with development of candidemia. Eur. J. Clin. Microbiol. Infect. Dis. 2005; 24:721-726.
76. Latgé JP. Aspergillus fumigatus and aspergillosis. Clin. Microbiol. Rev. 1999; 12:310- 350.
77. Latgé JP. The pathobiology of Aspergillus fumigatus. Trends Microbiol. 2001; 9:382- 389.
78. Brookman JL, Denning DW. Molecular genetics in Aspergillus fumigatus. Curr. Opin. Microbiol. 2000; 3:468-474.
79. Kontoyiannis DP, Bodey GP. Invasive aspergillosis in 2002: an update. Eur. J. Clin. Microbiol. Infect. Dis. 2002; 21:161-172.
80. Denning DW. Invasive aspergillosis. Clin. Infect. Dis. 1998; 26:781-803.
81. Ribaud P, Chastang C, Latgé JP, Baffroy-Lafitte L, Parquet N, Devergie A, Espérou H, Sélimi F, Rocha V, Espérou H, Sélimi F, Rocha V, Derouin F, Socié G, Gluckman E. Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation. Clin. Infect. Dis. 1999; 28:322-330.
82. Stevens DA, Kan VL, Judson MA, Morrison VA, Dummer S, Denning DW, Bennett JE, Walsh TJ, Patterson TF and Pankey GA. Practice guidelines for diseases caused by Aspergillus. Clin. Infect. Dis. 2000; 30:696-709.
83. Denning DW. Therapeutic outcome in invasive aspergillosis. Clin. Infect. Dis. 1996; 23:608-15.
84. Lin SJ, Schranz J and Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin. Infect. Dis. 2001; 32:358-66.
85. Cornet M, Fleury L, Maslo C, Bernard JF and Brucker G. Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area. J. Hosp. Infect. 2002; 51:288-296.
86. Singh N and Paterson DL. Aspergillus infections in transplant recipients. Clin. Microbiol. Rev. 2005; 18:44-69.
87. Denning DW. Aspergillus spp. and aspergillosis-progress on many fronts. Med. Mycol. 2006. 44:S1-S2.
88. Hedayati MT, Pasqualotto AC, Warn PA, Bowyer P and Denning DW. Aspergillus flavus: human pathogen, allergen and mycotoxin producer. Microbiology. 2007; 153:1677-1692.
89. Gerber J, Chomicki J, Brandsberg JW, Jones R and Hammerman KJ. Pulmonary aspergillosis caused by Aspergillus fischeri var. spinosus: report of a case and value of serologic studies. Am. J. Clin. Pathol. 1973; 60:861-866.
90. Guarro J, Kallas EG, Godoy P, Karenina A, Gene J, Stchigel A and Colombo AL. Cerebral aspergillosis caused by Neosartorya hiratsukae, Brazil. Emerg. Infect. Dis. 2002; 8:989-991.
91. Jarv H, Lehtmaa J, Summerbell RC, Hoekstra ES, Samson RA, and Naaber P. Isolation of Neosartorya pseudofischeri from blood: first hint of pulmonary aspergillosis. J. Clin. Microbiol. 2004; 42:925-928.
92. Balajee SA, Gribskov JL, Hanley E, Nickle D and Marr KA. Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus. Eukaryot. Cell 2005; 4:625-632.
93. Samson RA, Hong SB and Frisvad JC. Old and new concepts of species differentiation in Aspergillus. Med. Mycol. 2006; 44:133-148.
94. Stynen D, Goris A, Sarfati J and Latgé JP. A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J. Clin. Microbiol. 1995; 33:497-500.
95. Hamilton AJ, Holdom MD and Hay RJ. Specific recognition of purified Cu, Zn superoxidedismutase from Aspergillus fumigatus by immune human sera. J. Clin. Microbiol. 1995; 33: 495-496.
96. Patterson TF, Miniter P, Patterson JE, Rappeport JM and Andriole VT. Aspergillus antigen detection in the diagnosis of invasive aspergillosis. J. Infect. Dis. 1995; 171:1553-1558.
97. Jaúregui A, Martinez ML, Arnaiz I, Pontón J and Cisterna R. Estudio de la infección diseminada por Aspergillus fumigatus mediante la detección de quitina. Rev. Iberoam. Micol. 1994; 11:21-24.
98. López-Medrano R, Ovejero MC, Calera JA, Puente P and Leal F. An immunodominant 90-kilodalton Aspergillus fumigatus antigen is the subunit of a catalase. Infect. Immun. 1995; 63:4774-4780.
99. O'Sullivan CE, Kasai M, Francesconi A, Petraitis V, Petraitiene R, Kelaher AM, Sarafandi AA and Walsh TJ. Development and validation of a quantitative real-time PCR assay using fluorescence resonance energy transfer technology for detection of Aspergillus fumigatus in experimental invasive pulmonary aspergillosis. J. Clin. Microbiol. 2003; 41:5676-5682.
100. Scotter JM and Chambers ST. Comparison of galactomannan detection, PCR-enzymelinked immunosorbent ssay, and real-time PCR for diagnosis of invasive Aspergillosis in a neutropenic rat model and effect of caspofungin acetate. Clin. Diagn. Lab. Immunol. 2005; 12:1322-1327.
101. Spiess B, Buchheidt D, Baust C, Skladny H, Seifarth W, Zeilfelder U, Leib-Mösch C, Mörz H and Hehlmann R. Development of a LightCycler PCR assay for detection and quantification of Aspergillus fumigatus DNA in clinical samples from neutropenic patients. J. Clin. Microbiol. 2003; 41:1811-1818.
102. Baskova L, Landlinger C, Preuner S and Lion T. The Pan-AC assay: a single-reaction real-time PCR test for quantitative detection of a broad range of Aspergillus and Candida species. J. Med. Microbiol. 2007; 56:1167-1173.
103. Biwas J, Bagyalakshmi R and Therese L. Diagnosis of Aspergillus fumigatus endophthalmitis from formalin fixed paraffin-embedded tissue by polymerase chainreaction-based restriction fragment length polymorphism Indian J. Ophthalmol. 2008; 56:65-66.
104. Franzot SP, Salkin IF, Casadevall A. Cryptococcus neoformans var. grubii: separate varietial status for Cryptococcus neoformans serotype A isolates. J. Clin. Microbiol. 1999; 37:838-840.
105. Currie BP and Casadevall A. Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City. Clin. Infect. Dis. 1994; 19:1029-1033.
106. Illnait MT, Vilaseca JC, Fernández CM and Martínez GF. Enzyme-linked immunosorbent assay for detection and quantification of Cryptococcus neoformans antigen. Mem. Inst. Oswaldo Cruz. 2001; 96:241-245
107. Saha DC, Xess I, Biswas A, Bhowmik DM and Padma MV. Detection of Cryptococcus by conventional serological and molecular methods. J. Med. Microbiol. 2009; 58:1098- 1105.
108. Rachini A, Pietrella D, Lupo P, Torosantucci A, Chiani P, Bromuro C, Proietti C, Bistoni F, Cassone A and Vecchiarelli A. An anti-β-glucan monocolonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo. Infec. Immun. 2007; 75:5085-5094.
109. Scott EN, Muchmore HG and Felton FG. Enzyme-linked immunosorbent assays in murine cryptococcosis. Sabouraudia. 1981; 19: 257-265.
110. Casadevall A, Mukherjee J and Scharff MD. Monoclonal antibody based ELISAs for cryptococcal polysaccharide. J. Immunol. Methods. 1992; 154:27-35.
111. Frank UK, Nishimura SL, Li NC, Sugai K, Yajko DM, Hadley WK and Ng VL. Evaluation of an enzyme immunoassay for detection of cryptococcal capsular polysaccharide antigen in serum and cerebrospinal fluid. J. Clin. Microbiol. 1993; 31:97- 101.
112. Sekhon AS, Garg AK, Kaufman L, Kobayashi GS, Hamir Z, Jalbert M and Moledina N. Evaluation of a commercial enzyme immunoassay for the detection of cryptococcal antigen. Mycoses. 1993; 36:31-34.
113. Goodman JS, Kaufman L and Koenig R. 1971. Diagnosis of cryptococcal meningitis. Value of immunologic detection of cryptococcal antigen. N. Engl. J. Med. 1971; 285:434-436.
114. Prevost E and Newell R. Commercial cryptococcal latex kit: clinical evaluation in a medical center hospital. J. Clin. Microbiol. 1978; 8:529-533.
115. Hamilton AJ, Bartholomew MA, Fifueroa J, Fenelon LE and Hay RJ. Production of species-specific murine monoclonal antibodies agains Cryptococcus neoformans which recognize a noncapsular exoantigen. Clin. Microbiol. 1991; 29:980-984.
116. Hamilton AJ and Goodley J. Purification of the 115-kilodalton exoantigen of Cryptococcus neoformans and its recognition by immune sera. J. Clin. Microbiol. 1993; 31:335-339.
117. Kakeya H, Udono H, Maesaki S, Sasaki E, Kawamura S, Hossain MA, Yamamoto Y, Sawai T, Fukuda M, Mitsutake K, Miyazaki Y, Tomono K, Tashiro T, Nakayama E and Kohno S. Heat shock protein 70 (hsp70) as a major target of the antibody response in patients with pulmonary cryptococcosis. Clin. Exp. Immunol. 1999;115:485-490.
118. Biodo C, Messina L, Bombaci M, Mancuso G, Midiri A, Beninati C, Cusumano V, Gerace E, Papasergi S and Teti G. Characterization of two novel cryptococcal mannoproteins recognized by immune será. Infect. Immun. 2005; 73:7348-7355.
119. Gilbert NM, Donlin MJ, Gerik KJ, Specht CA, Djordjevic JT, Wilson CF, Sorrell TC and Lodge JK. KRE genes are required for β-1,6-glucan synthesis, maintenance of capsule architecture and cell wall protein anchorin in Cryptococcus neoformans. Mol. Microbiol. 2010; 76:517-534.
120. Klis FM, de Groot P and Hellingwerf K. Molecular organization of the cell wall of Candida albicans. Med. Mycol. 2001; 39:1-8.
121. Kondori N, Edebo L, Mattsby-Baltzer I. A novel monoclonal antibody recognizing β-(1-3) glucans in intact cells of Candida and Cryptococcus. APMIS. 2008; 116:867-876
122. Young M. Macias S, Thomas D and Wormley FL. A proteomic-based approach for the identification of immunodominant Cryptococcus neoformans proteins. Proteomics. 2009. 9:2578-2588.
123. Martins ML, Ferreira AS, Sampaio A, Vieira R and Inácio J. Direct and specific identification of Cryptococcus neoformans in biological samples using fluorescetly labeled DNA probes. Eur. J. Clin. Microbiol. Infect. Dis. 2010; 29:571-576.
124. Sidrim JJ, Costa AK, Cordeiro RA, Brilhante RS, Moura FE, Castelo-Branco DS, Neto MP and Rocha MF. Molecular methods for the diagnosis and characterization of Cryptococcus: a review. Can. J. Microbiol. 2010; 56:445-458.
125. Imwidthaya P and Poungvarin N. Cryptococcosis in AIDS. Postgred. Med. J. 2000; 76:85-88.
126. Paschoal RC, Hirata MH, Hirata RC, Melhem MS, Dias AL and Paula CR. 2004. Neurocryptococcosis: dianosis by PCR method. Rev. Inst. Med. Trop. Sao Paulo. 2004; 46:203-207.
127. Bialek R, Weiss M, Bekure-Nemariam K, Najvar LK, Alberdi MB, Graybill JR and Reishl U. Detection of Cryptococcus neoformans DNA in tissue samples by nested and real time PCR assay. Clin. Diagn. Lab. Immunol. 2002; 9:461-469.
128. Lopes-Bezerra LM, Schubach A and Costa RO. Sporothrix schenckii and sporotrichosis. An. Acad. Bras. Cienc. 2006; 78:293-308.
129. Ramos-e-Silva MC, Vasconcelos S and Carneiro T. Soprotrichosis, Clin. Dermatol. 2007; 25:181-187.
130. López-Romero E, Reyes-Montes MR, Pérez-Torres A, Ruiz-Baca E, Villagómez-Castro JC, Mora-Montes HM, Flores-Carreón A and Toriello C. Sporothrix schenckii complex and sporotrichosis, an emerging health problem. Future Microbiol. 2011; 6:85-102.
131. De Araujo T, Marques AC and Kerdel F. Sporotrichosis. Int. J. Dermatol. 2001; 40:737-742.
132. Aronso NE. Disseminated sporotrichosis. JAMA. 1992; 268:2021.
133. Zancope-Oliveira RM, De Almeida-Paes R, De Oliveira MME, Saraiva-Freitas DF and Gutierrez-Galhardo MC. New diagnostic applications in sporotrichosis. Cap. 4. 2011; p. 53-72.
134. Belknap BS. Sporotrichosis. Dermatol. Clín. 1989; 7:193-202.
135. Sindy H, Wen-Hung C, Suen-Iu H, Hsin-Chun H, Zen-Whe W, Chien-Hsun C, Shu-Chuan L, Tseng-tong K and Hong-Shang H. Detection of Sporothrix schenckii in clinical samples by a nested PCR assay. J. Clin. Microb. 2003; 4:1414-1418.
136. Berbee ML and Taylo JW. 18S ribosomal RNA gene sequence characters place the human pathogen Sporothrix schenckii in the genus Ophiostoma. Exp. Mycol. 1992; 16:87-91.
137. Davis BA. Sporotrichosis. Dermatol. Clin. 1996; 14:69-76.
138. Almeida-Paes R, Pimenta MA, Monteiro PC, Nosanchuk JD and Zancopé-Oliveira RM. Immunoglobulins G, M, and A against Sporothrix schenckii exoantigens in patients with sporotrichosis before and during treatment with itraconazole. Clin. Vaccine Immunol. 2007; 14:11491-157.
139. Almeida-Paes R, Pimenta MA, Pizzini CV, Monteiro PCF, Peralta JM, Nosanchuk JD and Zancopé-Oliveira RM. Use of mycelial-phase Sporothrix schenckii exoantigens in an Enzyme-linked Immunosorbent Assay for diagnosis of sporotrichosis by antibody detection. Clin. Vaccine Immunol. 2007; 14:244-249.
140. Lima OC and Lopes-Bezerra LM. Identification of a concanavalin A antigen of the cell surface of Sporothrix schenckii. J. Med. Vet. Mycol. 1997; 35:167-172.
141. Loureiro Y, Penha CV and Lopes-Bezerra LM. Concanavalin A-binding cell wall antigens of Sporothrix schenckii: a serological study. Med. Mycol. 2000; 38:1-7.
142. Bernardes-Engemann AR, Costa RC, Miguens BR, Penha CV, Neves E, Pereira BA, Dias CM, Matos M, Gutierrez-Galhardo MC, Schubach AO, Oliveira-Neto MP, Lazéra M and Lopes-Bezerra LM. Development of an enzyme-linked immunosorbent assay for the serodiagnosis of several clinical forms of sporotrichosis. Med. Mycol. 2005; 43:487-493.
143. Previato JO, Gorin PAJ, Haskins RH and Travassos LR. Soluble and insoluble glucans from different cell types of the human pathogen Sporothrix schenckii. Exp. Mycol. 1979; 3:92-105.
144. Lloyd KO and Bitoon MA 1971. Isolation and purification of a peptido-rhamnomannan from the yeast form of Sporothrix schenckii. Structural and immunochemical studies. J. Immunol. 1971; 107: 663-671.
145. Nakamura Y. Purification and isolation of a biologically active peptido-rhamnogalactan from Sporothrix schenckii. J. Dermatol. 1976; 3:25-29.
146. Ruiz-Baca E, Mora-Montes HM, López-Romero E, Toriello Conchita, Mojica Marín V and Urtiz-Estrada N. 2D-Immunoblotting analysis of Sporothrix schenckii cell wall. Mem. Instit. Oswaldo Cruz. 2011; 106:248-250.
147. Scott EN and Muchmore HG. Immunoblot analysis of antibody responses to Sporothrix schenckii. J. Clin. Microbiol. 1989; 27:300-304.
148. Bernardes-Engemann AR, Loureiro y Penha CV, Benvenuto F, Braga JU, Barros ML, Orofino-Costa R and Lopes-Bezerra LM. A comparative serological study of the SsCBF antigenic fraction isolated from three Sporothrix schenckii strains. Med. Mycol. 2009; 47: 874-878.
149. Ruiz-Baca E, Toriello C, Perez-Torres A, Sabanero-Lopez M, Villagomez-Castro JC and Lopez-Romero E. Isolation and some properties of a glycoprotein of 70 kDa (Gp70) from the cell wall of Sporothrix schenckii involved in fungal adherence to dermal extracellular matrix. Med. Mycol. 2009; 47: 185-196.
150. Nascimento RC and Almeida SR. Humoral immune response against soluble and fractionate antigens in experimental sporotrichosis. FEMS Immunol. Med. Microbiol. 2005; 43:241-247.
151. Kano R, Nakamura Y, Watanabe S, Tsujimoto H and Hasegawa A. Identificationof Sporothrix schenckii based on sequences of the chitin synthase 1 gene. Mycoses. 2001; 44:261-265.
152. Hu S, Chung WH, Hung SI, Ho HC, Wang ZW, Chen CH, Lu SC, Kuo TT and Hong HS. Detection of Sporothrix schenckii in clinical samples by a nested PCR assay. J. Clin. Microbiol. 2003; 41:1414-1418.
153. Berbee ML and Taylor JW. 18S ribosomal RNA gene sequence characters place the human pathogen Sporothrix schenckii in the genus Ophiostoma. Exp. Mycol. 1992; 16:87-91.
154. Xu TH, Lin JP, Gao XH, Wei H,Liao W and Chen HD. Identification of Sporothrix schenckii of various mtDNA types bye nested PCR assay. Med. Mycol. 2010; 48:161- 165
155. Sharman S, Choundhary R, Juneja M, Grover C and Nagi-Reddy BS. Cutaneous tuberculosis mimicking sporotrichosis. Indian Journal Pediatric. 2005; 72:86.
156. Brandshorst T and Klein B. Cell wall biogenesis of Blastomyces dermatitidis. J. Biol. Chem. 2000; 275:7925-7934.
157. Patel AJ, Gattuso P and Reddy VB. Diagnosis of blastomycosis in surgical pathology and cytopathology: correlation with microbiologic culture. Am. J. Surg. Pathol. 2010; 34:256-261.
158. Dworkin MS, Duckro AN, Proia L, Semel JD and Huhn G. The epidemiology of blastomycosis in Illinois and factors associated with death. Clin. Infect. Diseas. 2005; 41:107-111.
159. Tarr M, Marcinak J, Mongkolrattanothai K, Burns JL, Wheat LJ, Durkin M, Ismail M. Blastomyces antigen detection for monitoring progression of blastomycosis in a pregnant adolescent. Infect. Dis. Obstet. Gynecol. 2007; 2007: 89059.
160. Tenenbaum MJ, Greenspan J and Kerkering TM. Blastomycosis. Crit. Rev. Microbiol. 1982; 9:139-163.
161. Smith JA and Kauffman CA. Blastomycosis. Proc. Am. Thorac. Soc. 2010; 7(3):173-180.
162. Denton JF, McDonough ES, Ajello L and Ausherman RJ. Isolation of Blastomyces dermatitidis from soil. Science (Wash. DC). 1961; 133:1126-1127.
163. Klein BC and Jones JM. Isolation, purification, and radiolabeling of a novel 120 kDa surface protein on Blastomyces dermatitidis yeasts to detect antibody infected patients. J. Clin. Invest. 1990; 85:152-161.
164. Brömel C and Sykes JE. Epidemiology, diagnosis, and treatment of blastomycosis in dogs and cats. Clin. Tech. Small Anim. Pract. 2005; 20:233-339.
165. Bradsher RW. Systemic fungal infections: diagnosis and treatment. Infec. Dis. Clin. North. Am. 1988; 2:877-898.
166. Hurst SF and Kaufman L. Western Immunoblot analysis and serologic characterization of Blastomyces dermatitidis yeast form extracellular antigens. J. Clin. Microbiol. 1992; 30:3043-3049.
167. Turner S and Kaufman L. Immunodiagnosis of blastomycosis. Semin. Respir. Infect. 1986; 1:22-28.
168. Durkin M, Witt J, Lemonte A, Wheat B and Connolly P. Antigen assay with the potential to aid in diagnosis of blastomycosis. J. Clin. Microbiol. 2004; 42:4873-4875.
169. Kanetsuna F, Carbonell LM, Moreno RE and Rodriguez J. Cell wall composition of the yeast and mycelial forms of Paracoccidioides brasiliensis. J. Bacteriol. 1969; 97:1036- 1041.
170. Kanestsuna F and Carbonell LM. Cell wall composition of the yeastlike and mycelial forms of Blastomyces dermatitidis. J. Bacteriol. 1971; 106:946-948.
171. Green JH, Harrell WK, Johnson JE, Benson R. Preparation of reference antisera for laboratory diagnosis of blastomycosis. Clin. Microbiol. 1979; 10:1-7.
172. Cox RA and Lanh HW. Isolation Of skin test-active preparations from yeast-phase cells of Blastomyces dermatitidis. Infect. Immun. 1974; 10:48-53.
173. Lancaster MV and Sprouse RF. Isolation of a purified skin test antigen from Blastomyces dermatitidis yeast-phase cell wall. Infect. Immun. 1976; 14:623-625.
174. Young KD and Lanh HW. Identification of the active precipitin components in a purified preparation of the A antigen of Blastomyces dermatitidis. Infect. Immun. 1981; 33:171-177.
175. Spector D, Legendre AM, Wheat J, Bemis D, Rohrbach B, Taboada J and Durkin M. Antigen and antibody testing for the diagnosis of blastomycosis in dogs. J. Vet. Intern. Med. 2008; 22:839-843.
176. Klein BC and Jones JM. Purification and characterization of the major antigen WI-1 from Blastomyces dermatitidis yeast and immunological comparison with A antigen. Infect. Immun. 1994; 15:3890-3900.
177. Heiner DC. Diagnosis of histoplasmosis using precipitin reactions in agargel. Pediatrics. 1958; 22:616-627.
178. Zancopé-Oliveira RM, Bragg SL, Reiss E and Peralta JM. Immunochemical analysis of the H and M glycoproteins from Histoplasma capsulatum. Clin. Diagn. Lab. Immunol. 1994; 1:563-568.
179. Hamilton AJ, Bartholomew MA, Figueroa J, Fenelon LE and Hay RJ. Evidence that the M antigen of Histoplasma capsulatum var. capsulatum is a catalase which exhibits cross-reactivity with other dimorphic fungi. J. Med. Vet. Mycol. 1990; 28:479-485.
180. Standard PG and Kaufman L. Specific immunological test for the rapid identification of members of the genus Histoplasma. J. Clin. Microbiol. 1976; 3:191-199.
181. DiSalvo AF, Sekhon AS, Land GA and Fleming WH. Evaluation of the exoantigen test for identification of Histoplasma species and Coccidioides immitis cultures. J. Clin. Microbiol. 1980; 11: 238-241.
182. Zancopé-Oliveira RM, Reiss E, Lott TJ, Mayer LW and Deepe GS Jr. Molecular cloning, characterization, and expression of the M antigen of Histoplasma capsulatum. Infect. Immun. 1999; 67: 1947-1953.
183. Pizzini CV, Zancopé-Oliveira RM, Reiss E, Hajjeh R, Kaufman L and Peralta JM. Evaluation of a western blot test in an outbreak of acute pulmonary histoplasmosis. Clin. Diagn. Lab. Immunol. 1999; 6: 20-23.
184. Guimaraes AJ, Pizzini CV, Santoro DO, Albuquerque PC, Pimenta MA, et al. Evaluation of Enzyme Linked Immunosorbent Assay (ELISA) for Antibody Response in the Clinical Forms of Histoplasmosis, abstr. F-017, p 049 Abstr 105th Gen Meet Am Soc Microbiol American Society for Microbiology, Washington, DC. 2005.
185. Zancopé-Oliveira RM, Bragg SL, Hurst SF, Peralta JM and Reiss E. Evaluation of cation exchange chromatography for the isolation of M glycoprotein from histoplasmin. J. Med. Vet. Mycol. 1993; 31:29-41.
186. Zancopé-Oliveira RM, Bragg SL, Reiss E, Wanke B, Peralta JM. Effects of histoplasmin M antigen chemical and enzymatic deglycosylation on crossreactivity in the enzyme-linked immunoelectrotransfer blot method. Clin. Diagn. Lab. Immunol. 1994; 1:390-393.
187. Reiss E, Obayashi T, Orle K, Yoshida M and Zancope-Oliveira RM. Nonculture based diagnostic tests for mycotic infections. Med. Mycol. 2000; 38:147-159.
188. Zancopé-Oliveira RM, Reiss E, Lott TJ, Mayer LW, Deepe GS Jr. Molecular cloning, characterization, and expression of the M antigen of Histoplasma capsulatum. Infect Immun. 1999; 67: 1947-1953.
189. Guedes HL, Guimaraes AJ, Muniz Mde M, Pizzini CV, Hamilton AJ, Peralta JM, Deepe GS Jr and Zancopé-Oliveira RM. PCR assay for identification of Histoplasma capsulatum based on the nucleotide sequence of the M antigen. J. Clin. Microbiol. 2003; 41:535-539.
190. Reeves MW, Pine L, Kaufman L and McLaughlin D. Isolation of a new soluble antigen from the yeast phase of Histoplasma capsulatum. Appl. Microbiol. 1972; 4:841-843.
191. Reeves MW, Pine L and Bradley G. Characterization and evaluation of a soluble antigen complex prepared from the yeast phase of Histoplasma capsulatum. Infect. Immun. 1974; 9:1033-1044
192. Pine L. Histoplasma antigens: their production, purification and uses. Contrib. Microbiol. Immunol. 1977; 3:138-168.
193. Toriello C, Arjona-Rosado LC, Díaz-Gómez ML and Taylor ML. Efficiency of crude and purified fungal antigens in serodiagnosis to discriminate mycotic from other respiratory diseases. Mycoses. 1991; 34:133-140.
194. Toriello C, Jiménez-Montiel JA, Reyes-Montes MR and Taylor ML. Two-dimensional immunoelectrophoresis of histoplasmin and a purified polysaccharide-protein antigen of Histoplasma capsulatum. Mycopathologia. 1993; 122:7-13.
195. Taylor ML, Pedroza-Serés M, Gámez-Aranda A and Toriello C. Retrospective serological study of histoplasmosis in Mexico. Mycoses. 1993; 36:25-30.
196. Taylor ML and Bojalil LF. Immunology of histoplasmosis: isolation of a polysaccharide-protein complex with immuno-specific activity from Histoplasma capsulatum. Arch. Invest. Med. (Mex) 1977; 8:91-102.
197. Toriello C, Reyes-Montes MR and Taylor ML. Producción de antígenos fúngicos a partir de cepas autóctonas como ayuda para el inmunodiagnóstico de las micosis sistémicas en México. Rev. Invest. Clín. 1997; 49:5-13.
198. Taylor ML, Reyes-Montes MR, Lachica A, Eslava-Campos C, Olvera J and Maxwell R. Immunology of histoplasmosis: humoral and cellular activity from a polysaccharideprotein complex and its deproteinized fraction in experimentally immunized mice. Mycopathologia 1980; 71:159-166.
199. Green JH and Pine L. Preparation of H and M antigens of Histoplasma capsulatum free of heterologous antigens. Curr. Microbiol. 1985; 12:209-216.
200. Harris JE and Deepe GS Jr. Characterization of antigenic determinants in histoplasmin that stimulate Histoplasma capsulatum-reactive T cells in vitro. Infect. Immun. 1988; 56:2343-2349.
201. Hamilton AJ. Serodiagnosis of histoplasmosis, paracoccidioidomycosis and penicilliosis marneffei: current status and future trends. Med. Mycol. 1998; 36:351-364.
202. Deepe GS and Durose GG. Immunobiological activity of recombinant H antigen from Histoplasma capsulatum. Infect. Immun. 1995; 63:6151-6157.
203. Bracca A, Tosello ME, Girardini JE, Amigot SL, Gomez C and Serra E. Molecular detection of Histoplasma capsulatum var. capsulatum in human clinical samples. J. Clin. Microbiol. 2003; 41:1753-1755.
204. Guimarães AJ, Pizzini CV, De Abreu Almeida M, Peralta JM, Nosanchuk JD and Zancopé-Oliveira RM. Evaluation of an enzyme-linked immunosorbent assay using purified, deglycosylated histoplasmin for different clinical manifestations of histoplasmosis. Microbiol. Res. (Pavia). 2010; 2(1). doi: 10.4081/mr.2009.e1.
205. Chandrashekar R, Curtis KC, Rawot BW, Kobayashi GS and Weil GJ. Molecular cloning and characterization of a recombinant Histoplasma capsulatum antigen for antibody-based diagnosis of human histoplasmosis. J. Clin. Microbiol. 1997; 35:1071- 1076.
206. Wanke B and Londero AT 1994. Epidemiology and paracoccidioidomycosis infection. In M Franco, CS Lacaz, G Del Negro (eds.), Paracoccidioidomycosis, CRC Press, Boca Raton, p. 109-120.
207. Benard G. An overview of the immunopathology of human paracoccidioidomycosis. Mycopathologia. 2008; 165:209-221.
208. Puccia R, Schenkman S, Gorin PA and Travassos LR. Exocellular components of Paracoccidioides brasiliensis: identification of a specific antigen. Infect. Immun. 1986; 53:199-206.
209. Stambuk BU, Puccia R, Almeida MLC, Travassos LR and Schenkman S. Secretion of the 43 kDa glycoprotein antigen by Paracoccidioides brasiliensis. J. Med. Vet. Mycol. 1988; 26:367-373.
210. Puccia R and Travassos LR. 43-kilodalton glycoprotein from Paracoccidioides brasiliensis: immunochemical reactions with sera from patients with paracoccidioidomycosis, histoplasmosis, or Jorge Lobo's disease. J. Clin. Microbiol. 1991; 29:1610- 1615.
211. Marques da Silva SH, Colombo AL, Blotta MHSL, Lopes LD, Queiroz-Telles F and De Camargo ZP. Detection of circulating gp43 antigen in serum, cerebrospinal fluid and bronchoalveolar lavage of patients with paracoccidioidomycosis. J. Clin. Microbiol. 2003; 41:3675-3680.
212. Mattos Grosso D, de Almeida SR, Mariano M and Lopes JD. Characterization of gp70 and anti-gp70 monoclonal antibodies in Paracoccidioides brasiliensis pathogenesis. Infect. Immun. 2003; 71:6534-6542.
213. Blotta MHSL and Camargo ZP. Immunological response to cell-free antigens of Paracoccidioides brasilienis: relationship with clinical forms of paracoccidioidomycosis. J. Clin. Microbiol. 1993; 31:671-676.
214. Benard G, Mendes-Giannini MJS, Juvenale M, Miranda ET and Duarte AJS. Immunosuppression in paracoccidioidomycosis: T cell hyporesponsiveness to two Paracoccidioides brasiliensis glycoproteins that elicit strong humoral immune response. J. Infect. Dis. 1997; 175:1263-1267.
215. Salina MA, Shikanai-Yasuda MA, Mendes RP, Barravieira B, Mendes-Giannini MJS. Detection of circulating Paracoccidioides brasiliensis antigen in urine of paracoccidioidomycosis patients before and during treatment. J. Clin. Microbiol. 1998; 36:1723- 1728.
216. Gómez BL, Figueroa JL, Hamilton AJ, Ortiz B, Robledo MA, Hay RJ and Restrepo A. Use of monoclonal antibodies in diagnosis of paracoccidioidomycosis: new strategies for detection of circulating antigens. J. Clin. Microbiol. 1997; 35:3278-3283.
217. Cisalpino PS, Puccia R, Yamauchi LM, Cano MIN, Silveira JF and Travassos LR. Cloning, characterization, and epitope expression of the major diagnostic antigen of Paracoccidioides brasiliensis. J. Biol. Chem. 1996; 271:4553-4560.
218. McEwen JG, Ortiz BL, Garcia AM, Florez AM, Botero S and Restrepo A. Molecular cloning, nucleotide sequencing, and characterization of a 27-kDa antigenic protein from Paracoccidioides brasiliensis. Fungal Genet. Biol., 1996; 20:125.
219. Ortiz BL, Garcia AM, Restrepo A and McEwen JG. Immunological characterization of a recombinant 27-kilodalton antigenic protein from Paracoccidioides brasiliensis. Clin. Diagn. Lab. Immunol. 3 (1996); p. 239.
220. Ortiz BL, Díez S, Urán ME, Rivas JM, Romero M, Caicedo V, Restrepo A and McEwen JG. Use of the 27-kilodalton recombinant protein from Paracoccidioides brasiliensis in serodiganosis of paracoccidioidomycosis. Clin. Diag. Lab. Immunol. 1998; 5:826-830.
221. Cunha DA, Zancopé-Oliveira RM, Felipe MSS, Salem-Izaac SM, Deepe GS Jr and Soares CMA. Heterologous expression, purification and immunological reactivity of a recombinant HSP60 from Paracoccidioides brasiliensis. Clin. Diagn. Lab. Immunol. 2002; 9:374-377.
222. Díez S, Gómez BL, McEwen JG, Restrepo A, Hay RJ and Hamilton AJ. Combined use of Paracoccidioides brasiliensis recombinant 27-kilodalton and purified 87-kilodalton antigens in enzyme-linked immunoabsorbent assay for serodiagnosis of paracoccidioidomycosis. J. Clin. Microbiol. 2003;41: 1536-1542.
223. Fernandes VC, Coitinho JB, Veloso JMR, Araújo SA, Pedroso EP and Goes AM. Combined use of Paracoccidioides brasiliensis recombinant rPb27 and rPb40 antigens in an enzyme-linked immunosorbent assay for immunodiagnosis of paracoccidioidomycosis. J. Immunol. Methods. 2011; 367:78-84.
224. Goes TS, Goes VS, Kalapothakis E, Leite MF and Goes AM, Identification of immunogenic proteins from Paracoccidioides brasiliensis antigenic fractions F0, FII and FIII. Immunol. Lett. 2005; 101: p. 24.
225. Gomes GM, Cisalpino PS, Taborda CP and Camargo ZP. PCR for diagnosis of paracoccidioidomycosis. J .Clin. Microbiol. 2000; 38:3478-3480.
226. Bialek R, Ibricevic A, Aepinus C, Najvar Lk, Fothergill AW, Knobloch J and Graybill JR. Detection of Paracoccidioides brasiliensis in tissue samples by a nested PCR assay. J. Clin. Microbiol. 2000; 38:940-942.
227. Ricci G, Silva ID, Sano A, Borra RC and Franco M. Detection of P. brasiliensis by PCR in biopsies from patients with paracoccidioidomycosis: correlation with the histopathological pattern. Pathologica. 2007; 99:41-45.
228. Fisher MG, Koening GI, White TJ and Taylor JW. Molecular and phenotypic description of Coccidioides posadasii sp. Nov., previously recognized as the non-California population of Coccidioides immitis. Mycologia. 2002; 94:73-84.
229. Pappagianis D. Epidemiology of coccidioidomycosis. In: McGinnis MR, ed. Current topics in medical mycology.New York: Springer Verlag. 1988; p. 199-238.
230. Rippon JW. Medical mycology: the pathogenic fungi and pathogenic actinomycetes. Philadelphia: Harcourt Brace. 1988; p. 797.
231. Pappagianis D and Zimmer BL. Serology of coccidioidomycosis. Clin. Microbiol. Rev. 1990; 3:247-268.
232. Pappagianis D. Serologic studies in coccidioidomycosis. Semin. Respir. Infect. 2001; 16:242-250.
233. Smith CE, Saito MT and Simons SA. Pattern of 39,500 serologic tests in coccidioidomycosis. J. Am. Med. Assoc. 1956; 160:546-552.
234. Hung CY, Yu JJ, Lehmann PF and Cole GT. Cloning and expression of the gene which encodes a tube precipitin antigen and wall associated beta-glucosidase of Coccidioides immitis. Infect. Immun. 2001; 69:2211-2222.
235. Johnson SM and Pappagianis D. The coccidioidal complement fixation and immunodiffusion-complement fixation antigen is a chitinase. Infect. Immun. 1992; 60:2588-2592.
236. Martins TB, Jaskowski TD, Mouritsen CL and Hill HR. Comparison of commercially available enzyme immunoassay with traditional serological tests for detection of antibodies to Coccidioides immitis. J. Clin. Microbiol. 1995; 33:940-943.
237. Kaufman L, Sekhon AS, Moledina N, Jalbert M and Pappagianis D. Comparative evaluation of commercial Premier EIA and microimmunodiffusion and complement fixation tests for Coccidioides immitis antibodies. J. Clin. Microbiol. 1995; 33:618-619.
238. Blair JE, Coakley B, Santelli AC, Hentz JG and Wengenack NL. Serologic testing for symptomatic coccidioidomycosis in immunocompetent and immunosuppressed hosts. Mycopathologia. 2006; 162:317-324.
239. Blair JE and Currier JT. Significance of isolated positive IgM serologic results by enzyme immunoassay for coccidioidomycosis. Mycopathologia. 2008; 166:77-82.
240. Galgiani JN, Dugger KO, Ito JI and Wieden MA. Antigenemia in primary coccidioidomycosis. Am. J. Trop. Med. Hyg. 1984; 33:645-649.
241. Wack EE, Dugger KO and Galgiani JN. Enzyme-linked immunosorbent assay for antigens of Coccidioides immitis: human sera interference corrected by acidificationheat extraction. J. Lab. Clin. Med. 1988; 111:560-565.
242. Weiner MH. Antigenemia detected in human coccidioidomycosis. J. Clin. Microbio. 1983; l 18:136-142.
243. Kuberski T, Myers R, Wheat LJ, Durkin M, Connolly P, Kubak BM, Bruckner D and Pegues D. Diagnosis of coccidioidomycosis by antigen detection using cross-reaction with a Histoplasma antigen. Clin. Infect. Dis. 2007; 44:e50-4.
244. Durkin M, Connolly P, Kuberski T, Myers R, Kubak BM, Bruckner D, Pegues D and Wheat LJ. Diagnosis of coccidioidomycosis with use of the Coccidioides antigen enzyme immunoassay. Clin. Infect. Dis. 2008; 47:e69-73.
245. Crameri R. Recombinant Aspergillus fumigatus allergens: from the nucleotide sequences to clinical applications. Int. Arch. Allergy Immunol. 1998; 115:99-114.
246. Zimmermann CR, Johnson SM, Martens GW, White AG and Pappagianis D. Cloning and characterization of the complement fixation antigen-chitinase of Coccidioides immitis. Infect. Immun. 1996; 64:4976-4975.
247. Johnson SM, Zimmermann R and Pappagianis D. Use of a recombinant Coccidioides immitis complement fixation antigen-chitinase in conventional serological assays. J. Clin. Microbiol. 1996; 34:3160-3164.
248. Yang MC, Magee M, Kaufman L, Zhu Y and Cox RA. Recombinant Coccidioides immitis complement-fixing antigen: detection of an epitope shared by Coccidiodesimmitis, Histoplasma capsulatum, and Blastomyces dermatitidis. Clin. Diag. Lab. Immunol 1997; 4:19-22.
249. Peng T, Orsborn KI, Orbach MJ and Galgiani JN. Proline-rich vaccine candidate antigen of Coccidioides immitis: conservation among isolates and differential expression with spherule maturation. J. infect. Dis. 1999; 179:518-521.
250. Orsborn KI and Galgiani JN. Detecting serum antibodies to a purified recombinant proline-rich antigen of Coccidioides immitis in patients with coccidioidomycosis. Clin. Infect. Dis. 1998; 27:1475-1478.
251. Millar BC, Jiru X, Walker J, Evans JP and Moore JE. False identification of Coccidioides immitis: do molecular methods always get it right?. J. Clin. Microbiol. 2003; 41:5778-5780.
252. Greene DR, Koenig G, Fisher MC and Taylor JW. Soil isolation and molecular identification of Coccidioides immitis. Mycologia. 2000; 92:406-410.
253. Pan S, Sigler L and Cole GT. Evidence for a phylogenetic connection between Coccidioides immitis and Uncinocarpus reesii (Onygenaceae). Microbiology. 1994; 140:1481-1494
254. Bialek R, Kern J, Herrmann T, Tijerina R, Ceceñas L, Reischl U and González GM. PCR assays for identification of Coccidioides posadasii based on the nucleotide sequence of the antigen 2/proline-rich antigen. J. Clin. Microbiol. 2004; 42:778-783.
255. Umeyama T, Sano A, Kamei K, Niimi M, Nishimura K and Uehara Y. Novel approach to design primers for identification and distinction of the human pathogenic fungi Coccidioides immitis and Coccidioides posadasii by PCR amplification. J. Clin. Microbiol. 2006; 44:1859-1862.
256. Tintelnot K, De Hoog GS, Antweiler E, Losert H, Seibold M, Brandt Ma, Gerrits Van Den Ende AHG and Fisher Mc. Taxonomic and diagnostic markers for identification of Coccidioides immitis and Coccidioides posadasii. Med. Micol. 2007; 45:385-393.
257. Binnicker MJ, Buckwalter SP, Eisberner JJ, Stewart RA, McCullough AE, Wohlfiel SL, Wengenack NL. Detection of Coccidioides species in clinical specimens by realtime PCR. J. Clin. Microbiol. 2007; 45:173-178.
258. Sheff KW, York ER, Driebe EM, Barker BM, Rounsley SD, Waddell VG, Beckstrom-Sternberg SM, Beckstrom-Sternberg JS, Keim PS and Engelthaler DM. Development of a rapid, cost-effective TaqMan Real-Time PCR Assay for identification and differentiation of Coccidioides immitis and Coccidioides posadasii. Med. Mycol. 2010; 48:466- 469.
259. Koufopanou V, Burt A and Taylor JW. Concordance of gene genealogies reveals reproductive isolation in the pathogenic fungus. Proc. Natl. Acad. Sci. USA. 1997; 94:5478-5482.
260. Castañón-Olivares LR, Güereña-Elizalde D, González-Martínez MR, Licea-Navarro AF, González-González GM and Aroch-Calderón A. Molecular identification of Coccidioides isolates from Mexican patients. Ann. N. Y. Acad. Sci. 2007; 1111:326- 335.
261. Mennink-Kersten MA, Donnelly JP and Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet. Infect. Dis. 2004; 4:349-357.